!!Michele Vendruscolo - Curriculum Vitae
\\
__Education:__
\\
*1992, Laurea (BSc) in Physics (with honors), University of Trieste, Italy\\
*1993, MSc in Condensed Matter Physics, Intern. School for Advanced Studies, Trieste, Italy\\
*1996, PhD in Condensed Matter Physics (with honors), Intern. School for Advanced Studies, Trieste, Italy\\
\\
__Academic Appointments:__
\\
*1996 – 1998: Weizmann Institute, (Israel), Sir Charles Clore Postdoctoral Fellow\\
*1999 – 2001: University of Oxford, EMBO Long-Term Fellow\\
*2001 – 2009: University of Cambridge, Royal Society University Research Fellow\\
*2006 – 2008: University of Cambridge, Lecturer in Theoretical Chemical Biology\\
*2008 – 2010: University of Cambridge, Reader in Theoretical Chemical Biology\\
*2010 – present: University of Cambridge, Professor of Biophysics\\
\\
__Other Appointments:__
\\
*2003 – 2006: Research Fellow, Clare Hall, Cambridge\\
*2003 – 2010: Associate Editor, Molecular Biology and Evolution\\
*2007 – 2010: EMBO Young Investigator\\
*2009 – 2015: European Physical Society, Division of Physics of Life Sciences, Executive Board\\
*2010 – 2016 : Faculty of 1000, Faculty Member, Protein Folding\\
*2011:   European Research Council, PE3 Panel Member – Condensed Matter Physics\\
*2015:   Director, Centre for Protein Misfolding Diseases, Cambridge\\
*2016:   Founder and Chief Scientific Officer, Wren Therapeutics, Cambridge.\\
\\
__Academic Honours include:__
\\
*2007 – EMBO Young Investigator.\\
*2007 – Jean-Francois Levefre Lecture, Strasbourg (France).\\
*2012 – Giorgio Careri Memorial Lecture, Rome (Italy).\\
*2013 – Soft Matter & Biophysical Chemistry Award, Royal Society of Chemistry.\\
*2013 – Fellow of the Royal Society of Chemistry.\\
\\
__Invited Talks:__
\\ \\
Over 300 lectures at international meetings, schools and universities.\\
\\
__Other information:__
\\
*Grants with over £38,000,000 received so far (€ 44,500,000)\\
*Organisation of over 20 international meetings\\
*8 patents related to methodologies for controlling protein aggregation, protein solubility and antibody design.\\ \\